Description

Finerenone Tablets Description

Product name: Finerenone tablets (Keshenda)
Packaging specifications: 10mg*28 tablets  Product dosage form: tablets  Packaging unit: box
Approval number: National Medicine Standard HJ20220057  Drug standard code: 86978262000420
Manufacturer: Bayer AG, Germany
Product barcode: 6924147600869

Finerenone is a novel, non-steroidal, and selective mineralocorticoid receptor antagonist (MRA) approved for use in adults with chronic kidney disease associated with Type 2 diabetes. Clinical trials show it can significantly reduce the risk of kidney failure, cardiovascular death, and hospitalization due to heart failure.

First approved in China in June 2022 under NMPA number HJ20220057, Kerendia offers a powerful new treatment option with dual renal and cardiac protection. It was also added to the national reimbursement list in January 2023, improving patient accessibility.

 Product Specifications

 Mechanism of Action & Clinical Highlights

• Selective MRA: Blocks mineralocorticoid receptors in kidneys, heart, and blood vessels, reducing inflammation and fibrosis zh.wikipedia.org

• Renal protection: FIDELIO-DKD trial showed an 18% reduction in composite renal endpoints.

• Cardiovascular benefit: 14% reduction in cardiovascular events in CKD patients with T2D.

• Hyperkalemia risk: Up to 18.3% incidence—requires serum potassium monitoring.

• Blood pressure effect: Modest decreases in systolic (~2–4mmHg) / diastolic (~1–2mmHg) readings.

Why Choose Kerendia Finerenone?

• First-in-class MRA with strong evidence in CKD + T2D

• Backed by global RCTs and Chinese clinical data

• Available in research-ready blister format

• Ideal for metabolic, nephrology, and cardiovascular research

Related Research Compounds

• Spironolactone / Eplerenone (Steroidal MRAs)

• SGLT 2 inhibitors (e.g., Dapagliflozin)

• GLP-1 RAs (e.g., Semaglutide, Liraglutide)

Summary

Kerendia (Finerenone 10mg) is a high-quality, research-focused MRA with robust renal and cardiovascular evidence. Manufactured by Bayer, NMPA-approved, and blister-packed for lab use.

Reminder: strictly for laboratory research or analytical use only — not for human consumption or therapy.